Cascade Prodrug, Inc. — Form D/A
Cascade Prodrug, Inc. of Portland, OR, a company, filed a Form D amendment with the SEC on 2019-05-07. The offering totals $500K, of which $250K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-05-07
- Form: D/A
- Accession: 0001541764-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $250K
- Remaining: $250K
- Minimum investment: $25K
- Investors: 2
- Date of first sale: 2017-12-19
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-301129
Issuer
- Name: Cascade Prodrug, Inc.
- CIK: 0001541764
- Entity type: Corporation
- Jurisdiction: OREGON
- Incorporated: 2009
- Address: c/o Ater Wynne LLP, Portland, OR, 97209
- Phone: (541) 343-6025
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Allan G Cochrane | Director | Eugene, OR |
| Christopher G Schelling | Director | Eugene, OR |
| August G Sick | Director | Eugene, OR |
| Lynnor G Stevenson | Director | Eugene, OR |
| Allan G Cochrane | Executive Officer | Eugene, OR |
| August G Sick | Executive Officer | Eugene, OR |
| Allan Cochrane | Director | Eugene, OR |
| Allan Cochrane | Executive Officer | Eugene, OR |
| Allan Cochrane | Promoter | Eugene, OR |
| August Sick | Director | Eugene, OR |
| August Sick | Executive Officer | Eugene, OR |
| August Sick | Promoter | Eugene, OR |
| Lynnor B Stevenson | Director | Portland, OR |
Other filings by this issuer (7)
More